Strikingly, the top-ranked gene – CRISP3 – showed a massive fold increase in ERG-positive carcinomas as compared to both non-malignant tissue and ERG-negative carcinomas, which led us to validate and study this candidate target further. Here, ERG is linked to carcinoma.